New hope for kids with untreatable autoimmune diseases
NCT ID NCT07490041
Summary
This early-stage study is testing a new cell therapy called CAR-NK for children with severe rheumatic diseases that haven't responded to standard treatments. Doctors will give a single infusion of these specially modified immune cells to see if it's safe and can help put the disease into remission. The study will enroll 36 children aged 5 and older who have conditions like lupus or juvenile arthritis that other drugs can't control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Children's Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.